Metraipolis › archive › dc_69730cf2e4a2
EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy — Europe PMC PMID:41087486
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41087486
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T08:24:04.088Z
- SHA-256 of the archived text
cdb73529538d0df17c3e1002ca14f7ca4032551a886d79251e7d34b49ed6d620- Stable URL of this page
https://metraipolis.com/documento/dc_69730cf2e4a2
How to cite
EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy — Europe PMC PMID:41087486 — Europe PMC (en), https://europepmc.org/article/MED/41087486 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69730cf2e4a2 (Metraipolis archive dc_69730cf2e4a2, sha256 cdb73529538d0df17c3e1002ca14f7ca4032551a886d79251e7d34b49ed6d620)
BibTeX
@misc{dc69730cf2e4a2,
title = {EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy — Europe PMC PMID:41087486},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41087486},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69730cf2e4a2; sha256 cdb73529538d0df17c3e1002ca14f7ca4032551a886d79251e7d34b49ed6d620},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41087486. Agents can read the archived copy with the MCP tool read_document.